ELDN Stock-Based Compensation
Eledon Pharmaceuticals Inc · Stock-Based Compensation
ELDN Stock-Based Compensation
Latest reported$10.25Mperiod ending
ELDN TTM Stock-Based Comp ($2.11M → $10.25M)
TTM stock-based compensation
High-resolution chart · PNG
ELDN stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 10,249,000 | |
| 9,789,000 | |
| 10,451,000 | |
| 14,568,000 | |
| 13,923,000 | |
| 14,292,000 | |
| 13,122,000 | |
| 8,250,000 | |
| 8,201,000 | |
| 6,858,000 | |
| 6,545,000 | |
| 6,309,000 | |
| 6,760,000 | |
| 7,348,000 | |
| 5,967,000 | |
| 6,546,000 | |
| 6,404,000 | |
| 6,130,000 | |
| 7,904,000 | |
| 7,510,000 | |
| 6,345,000 | |
| 4,508,000 | |
| 3,171,000 | |
| 1,755,000 | |
| 1,104,000 | |
| 1,534,000 | |
| 1,308,000 | |
| 1,805,000 | |
| 1,816,000 | |
| 1,593,000 | |
| 1,543,000 | |
| 996,000 | |
| 908,000 | |
| 634,000 | |
| 579,000 | |
| 728,000 | |
| 635,000 | |
| -432,000 | |
| 484,000 | |
| 999,000 | |
| 1,746,000 | |
| 3,289,000 | |
| 2,901,000 | |
| 2,633,000 | |
| 3,008,000 | |
| 2,652,000 | |
| 2,108,000 | |
| 1,620,000 | |
| 488,000 |